APGE Q4 2024 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

APGEApogee Therapeutics, Inc.

$4B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$76M

Net Income

-$67M

EPS (Diluted)

$-1.22

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$68M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$754M

Total Liabilities

$37M

Stockholders' Equity

$717M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$76M	-$37M	-104.2%
Net Income	-$67M	-$32M	-111.8%